SCHEMBL237695

SCHEMBL237695

N=C(N)Nc1ccc(C(=O)Oc2ccc([N+](=O)[O-])cc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 9/20 0.64
▸ PKM P14618 1/20 0.64
▸ HGFAC Q04756 1/20 0.61
▸ MEN1 O00255 7/20 0.56
▸ MAPT P10636 8/20 0.54
▸ RAB9A P51151 4/20 0.54
▸ NPC1 O15118 4/20 0.54
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ NPSR1 Q6W5P4 2/20 0.53
▸ HTT P42858 2/20 0.53
▸ MAPK1 P28482 2/20 0.52
▸ MYOC Q99972 1/20 0.52
▸ GAA P10253 2/20 0.49
▸ CA12 O43570 1/20 0.49
▸ CA1 P00915 1/20 0.49
▸ CA2 P00918 1/20 0.49
▸ CA9 Q16790 1/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ NR1H4 Q96RI1 1/20 0.48
▸ LMNA P02545 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL377076 0.99 KMT2A (0.63) KMT2APKMHGFACMEN1MAPT
SCHEMBL10956570 0.87 KMT2A (0.56) KMT2AHGFACMEN1MAPTSMN1; SMN2
SCHEMBL9474762 0.85 KMT2A (0.72) KMT2APKMHGFACMEN1MAPT
SCHEMBL11316711 0.83 PARP10 (0.61) KMT2AHGFACMEN1RAB9ANPC1
SCHEMBL542043 0.83 KMT2A (0.84) KMT2APKMHGFACMAPTRAB9A
SCHEMBL18434657 0.83 KMT2A (0.84) KMT2APKMHGFACMAPTRAB9A
SCHEMBL4951809 0.83 KMT2A (0.84) KMT2APKMHGFACMAPTRAB9A
SCHEMBL1740370 0.83 KMT2A (0.63) KMT2AMEN1MAPTRAB9ANPC1
SCHEMBL10636579 0.83 KMT2A (0.84) KMT2APKMHGFACMAPTRAB9A
SCHEMBL7328271 0.82 ACR (0.58) KMT2AHGFACMEN1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 291 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12559735-B2 Device for detecting organophosphates PLANTVAX, INC. (US) 2026-02-24 — — US claimed
US-20220062906-A1 DEVICE FOR DETECTING ORGANOPHOSPHATES PLANTVAX, INC. (US) 2022-03-03 — — US claimed
CN-113784801-A Organic phosphorus detection device 普兰特瓦可思公司 2021-12-10 — — CN claimed
WO-2020227413-A1 DEVICE FOR DETECTING ORGANOPHOSPHATES PLANTVAX, INC. (US) 2020-11-12 — — WO claimed
US-7071004-B1 14094, a novel human trypsin family member and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2006-07-04 — — US claimed
EP-1553171-A1 NOVEL ENZYME FORMING PEPTIDE, MICROORGANISM PRODUCING THE SAME AND PROCESS FOR PRODUCING DIPEPTIDE USING THEM Ajinomoto Co., Inc. (JP) 2005-07-13 — — EP claimed
US-20050032187-A1 Novel peptide-forming enzyme, microbe producing the enzyme and method for producing peptide using them AJINOMOTO CO., INC. (JP) 2005-02-10 — — US claimed
US-20040253665-A1 Novel peptide-producing enzyme, microbe producing the enzyme and method for dipeptide synthesis using them AJINOMOTO CO., INC. (JP) 2004-12-16 — — US claimed
US-20030033622-A1 Transgenic insect IMPLYX LTD. (GB) 2003-02-13 — — US claimed
EP-1242607-A1 TRANSGENIC INSECT Implyx Ltd. (GB) 2002-09-25 — — EP claimed
EP-0024781-B1 MEDICATED INTRAUTERINE DEVICES Shaw, Seth Thomas, Jr. (US) 1984-08-08 — — EP claimed
EP-0009879-B1 ENZYME DERIVATIVES FOR USE IN THE TREATMENT OF VENOUS THROMBOSIS, COMPOSITIONS CONTAINING THEM AND THEIR PREPARATION BEECHAM GROUP PLC (GB) 1983-10-12 — — EP claimed
EP-0028489-B1 ENZYME DERIVATIVES, AND THEIR PREPARATION BEECHAM GROUP PLC (GB) 1983-10-05 — — EP claimed
US-4381001-A A GUANIDINE IN POLYMER MATRIX; ANTIFERTILITY AGENTS AND ANTICOAGULANTS; SUSTAINED RELEASE SHAW JR SETH T (US) 1983-04-26 — — US claimed
US-4285932-A Enzyme derivatives for use in the treatment of venous thrombosis BEECHAM GROUP LIMITED (GB) 1981-08-25 — — US claimed
EP-0028489-A1 Enzyme derivatives, and their preparation BEECHAM GROUP PLC (GB) 1981-05-13 — — EP claimed
EP-0024781-A1 Medicated intrauterine devices Shaw, Seth Thomas, Jr. (US) 1981-03-11 — — EP claimed
EP-0024780-A1 Medicated intrauterine devices Shaw, Seth Thomas, Jr. (US) 1981-03-11 — — EP claimed
EP-0024779-A1 Drugs for use with intrauterine devices and intrauterine devices containing said drugs Shaw, Seth Thomas, Jr. (US) 1981-03-11 — — EP claimed
EP-0009879-A1 Enzyme derivatives for use in the treatment of venous thrombosis, compositions containing them and their preparation BEECHAM GROUP PLC (GB) 1980-04-16 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12559735-B2 Device for detecting organophosphates BCHE, LIPE, ACHE KMT2A 1231/4885PKM 4307/4885HGFAC 2367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback